百克生物：关于自愿披露吸附无细胞百白破b型流感嗜血杆菌联合疫苗临床试验申请获得批准的公告

Core Viewpoint - The company, Baike Biological, has received approval from the National Medical Products Administration for a clinical trial of its combined vaccine for pertussis, diphtheria, and influenza type B [2] Group 1 - Baike Biological announced the receipt of the clinical trial approval notice for its acellular pertussis, diphtheria, and influenza type B vaccine [2]